Welcome to LookChem.com Sign In|Join Free

CAS

  • or

99822-23-8

Post Buying Request

99822-23-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

99822-23-8 Usage

Uses

5-Fluorobenzo[d]isoxazol-3(2H)-one is a useful reactant for the preparation of novel benzopyran derivatives as potassium channel openers.

Check Digit Verification of cas no

The CAS Registry Mumber 99822-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,8,2 and 2 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 99822-23:
(7*9)+(6*9)+(5*8)+(4*2)+(3*2)+(2*2)+(1*3)=178
178 % 10 = 8
So 99822-23-8 is a valid CAS Registry Number.

99822-23-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Fluorobenzo[d]isoxazol-3(2H)-one

1.2 Other means of identification

Product number -
Other names 5-fluoro-1,2-benzoxazol-3-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:99822-23-8 SDS

99822-23-8Downstream Products

99822-23-8Relevant articles and documents

Benzo[d]isoxazol-3-ol DAAO inhibitors

-

Page/Page column 10, (2010/02/12)

Methods for increasing D-Serine concentration and reducing concentration of the toxic products of D-Serine oxidation, for enhancing learning, memory and/or cognition, or for treating schizophrenia, Alzheimer's disease, ataxia, or neuropathic pain, or preventing loss in neuronal function characteristic of neurodegenerative diseases involve administering to a subject in need of treatment a therapeutic amount of a compound of formula I, or a pharmaceutically acceptable salt or solvate thereof: wherein Z1 is N or CR3; Z2 is N or CR4; Z3is O or S; A is hydrogen, alkyl or M+; M is aluminum, calcium, lithium, magnesium, potassium, sodium, zinc or a mixture thereof; R1, R2, R3 and R4 are independently selected from hydrogen, alkyl, hydroxy alkoxy, aryl, acyl, halo, cyano, haloalkyl, NHCOOR5 and SO2NH2; R5 is aryl, arylalkyl, heteroaryl or heteroarylalkyl; at least one of R1, R2, R3 and R4 is other than hydrogen; and at least one of Z1 and Z2 is other than N.

Azabicyclic 5HT1 receptor ligands

-

, (2008/06/13)

The present invention relates to compounds of the formula These compounds are useful as psychotherapeutic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 99822-23-8